Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, Berzaczy D, Raderer M, Preusser M, Hochmair M, Kiesewetter B, Scheuba C, Ba-Ssalamah A, Karanikas G, Kesselbacher J, Prager G, Dieckmann K, Polterauer S, Weber M, Rausch I, Brauner B, Eidherr H, Wadsak W, Haug AR.

Eur J Nucl Med Mol Imaging. 2019 Aug 13. doi: 10.1007/s00259-019-04452-y. [Epub ahead of print]

PMID:
31410538
2.

Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT.

Nakuz TS, Millinger FP, El-Rabadi K, Weber M, Pichler V, Wadsak W, Mitterhauser M, Haug A, Hacker M, Karanikas G, Pietschmann P, Agis H.

Anticancer Res. 2019 Apr;39(4):1943-1952. doi: 10.21873/anticanres.13304.

PMID:
30952737
3.

FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.

Lötsch F, Waneck F, Groger M, Auer H, Kaczirek K, Rausch I, Wadsak W, Hacker M, Lagler H, Ramharter M, Karanikas G.

Trop Med Int Health. 2019 Jun;24(6):663-670. doi: 10.1111/tmi.13228. Epub 2019 Mar 27.

4.

Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?

Brammen L, Niederle MB, Riss P, Scheuba C, Selberherr A, Karanikas G, Bodner G, Koperek O, Niederle B.

Ann Surg Oncol. 2018 Dec;25(13):3919-3927. doi: 10.1245/s10434-018-6829-3. Epub 2018 Oct 10.

5.

[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.

Rasul S, Hartenbach S, Rebhan K, Göllner A, Karanikas G, Mayerhoefer M, Mazal P, Hacker M, Hartenbach M.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2159-2169. doi: 10.1007/s00259-018-4045-9. Epub 2018 May 15.

6.

[11C]acetate PET as a tool for diagnosis of liver steatosis.

Nejabat M, Leisser A, Karanikas G, Wadsak W, Mitterhauser M, Mayerhöfer M, Kienbacher C, Trauner M, Hacker M, Haug AR.

Abdom Radiol (NY). 2018 Nov;43(11):2963-2969. doi: 10.1007/s00261-018-1558-4.

7.

[18F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [18F]FDG-PET/MRI.

Anner P, Mayerhöfer M, Wadsak W, Geleff S, Dudczak R, Haug A, Hacker M, Karanikas G.

Oncol Lett. 2018 Mar;15(3):3951-3956. doi: 10.3892/ol.2018.7775. Epub 2018 Jan 12.

8.

Clinical Value of 18F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma.

Nakuz TS, Berger E, El-Rabadi K, Wadsak W, Haug A, Hacker M, Karanikas G.

Anticancer Res. 2018 Jan;38(1):353-358.

PMID:
29277794
9.

Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.

Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Simonitsch-Klupp I, Raderer M, Mayerhoefer ME.

Acad Radiol. 2018 Apr;25(4):453-460. doi: 10.1016/j.acra.2017.10.024. Epub 2017 Dec 1.

PMID:
29199055
10.

Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging.

Giraudo C, Karanikas G, Weber M, Raderer M, Jaeger U, Simonitsch-Klupp I, Mayerhoefer ME.

J Magn Reson Imaging. 2018 May;47(5):1217-1226. doi: 10.1002/jmri.25884. Epub 2017 Oct 31.

PMID:
29086453
11.

Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.

Poetsch N, Woehrer A, Gesperger J, Furtner J, Haug AR, Wilhelm D, Widhalm G, Karanikas G, Weber M, Rausch I, Mitterhauser M, Wadsak W, Hacker M, Preusser M, Traub-Weidinger T.

Neuro Oncol. 2018 Feb 19;20(3):411-419. doi: 10.1093/neuonc/nox177.

12.

FDG-PET/MRI in alveolar echinococcosis.

Lötsch F, Waneck F, Auer H, Kaczirek K, Karanikas G, Ramharter M.

Int J Infect Dis. 2017 Nov;64:67-68. doi: 10.1016/j.ijid.2017.09.006. Epub 2017 Sep 19. No abstract available.

13.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

Somasundaram R, Zhang G, Fukunaga-Kalabis M, Perego M, Krepler C, Xu X, Wagner C, Hristova D, Zhang J, Tian T, Wei Z, Liu Q, Garg K, Griss J, Hards R, Maurer M, Hafner C, Mayerhöfer M, Karanikas G, Jalili A, Bauer-Pohl V, Weihsengruber F, Rappersberger K, Koller J, Lang R, Hudgens C, Chen G, Tetzlaff M, Wu L, Frederick DT, Scolyer RA, Long GV, Damle M, Ellingsworth C, Grinman L, Choi H, Gavin BJ, Dunagin M, Raj A, Scholler N, Gross L, Beqiri M, Bennett K, Watson I, Schaider H, Davies MA, Wargo J, Czerniecki BJ, Schuchter L, Herlyn D, Flaherty K, Herlyn M, Wagner SN.

Nat Commun. 2017 Sep 19;8(1):607. doi: 10.1038/s41467-017-00452-4.

14.

Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.

Polanec SH, Andrzejewski P, Baltzer PAT, Helbich TH, Stiglbauer A, Georg D, Karanikas G, Susani M, Wadsak W, Margreiter M, Mitterhauser M, Brader P, Pinker K.

PLoS One. 2017 Jul 18;12(7):e0180790. doi: 10.1371/journal.pone.0180790. eCollection 2017.

15.

Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.

Berzaczy D, Giraudo C, Haug AR, Raderer M, Senn D, Karanikas G, Weber M, Mayerhoefer ME.

Clin Nucl Med. 2017 Sep;42(9):669-674. doi: 10.1097/RLU.0000000000001753.

16.

Influence of PET reconstruction technique and matrix size on qualitative and quantitative assessment of lung lesions on [18F]-FDG-PET: A prospective study in 37 cancer patients.

Riegler G, Karanikas G, Rausch I, Hirtl A, El-Rabadi K, Marik W, Pivec C, Weber M, Prosch H, Mayerhoefer M.

Eur J Radiol. 2017 May;90:20-26. doi: 10.1016/j.ejrad.2017.02.023. Epub 2017 Feb 20.

PMID:
28583635
17.

Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.

Georg P, Andrzejewski P, Baltzer P, Daniel M, Wadsak W, Mitterhauser M, Sturdza A, Majercakova K, Karanikas G, Pötter R, Hacker M, Helbich T, Georg D, Pinker K.

Mol Imaging Biol. 2018 Feb;20(1):160-169. doi: 10.1007/s11307-017-1087-5.

18.

Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by 18F-Fluoride and 18F-FDG.

Li X, Heber D, Cal-Gonzalez J, Karanikas G, Mayerhoefer ME, Rasul S, Beitzke D, Zhang X, Agis H, Mitterhauser M, Wadsak W, Beyer T, Loewe C, Hacker M.

J Nucl Med. 2017 Jun;58(6):968-974. doi: 10.2967/jnumed.116.182790. Epub 2017 Feb 23.

19.

Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.

Mayerhoefer ME, Karanikas G, Kletter K, Kiesewetter B, Weber M, Rausch I, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M.

Clin Nucl Med. 2016 Nov;41(11):837-843.

PMID:
27648705
20.

Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.

Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Staudenherz A, Senn D, Raderer M, Weber M, Simonitsch-Klupp I, Mayerhoefer ME.

PLoS One. 2016 Oct 10;11(10):e0164118. doi: 10.1371/journal.pone.0164118. eCollection 2016.

21.

Fever of unknown origin (FUO) revised.

Unger M, Karanikas G, Kerschbaumer A, Winkler S, Aletaha D.

Wien Klin Wochenschr. 2016 Nov;128(21-22):796-801. Epub 2016 Sep 26. Review.

22.

Presurgical evaluation of pediatric epilepsy patients prior to hemispherotomy: the prognostic value of 18F-FDG PET.

Traub-Weidinger T, Weidinger P, Gröppel G, Karanikas G, Wadsak W, Kasprian G, Dorfer C, Dressler A, Muehlebner A, Hacker M, Czech T, Feucht M.

J Neurosurg Pediatr. 2016 Dec;25(6):683-688. Epub 2016 Sep 9.

PMID:
27611898
23.

Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.

El-Rabadi K, Weber M, Mayerhofer M, Nakuz T, Scherer T, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.

Anticancer Res. 2016 Aug;36(8):4187-93.

PMID:
27466530
24.

**-Postprandial pancreatic [11C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release.

Steiner E, Kazianka L, Breuer R, Hacker M, Wadsak W, Mitterhauser M, Stimpfl T, Reiter B, Karanikas G, Miholic J.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):509-516. doi: 10.1007/s00259-016-3451-0. Epub 2016 Jul 7.

25.

Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.

Leithner D, Baltzer PA, Magometschnigg HF, Wengert GJ, Karanikas G, Helbich TH, Weber M, Wadsak W, Pinker K.

J Nucl Med. 2016 Oct;57(10):1518-1522. Epub 2016 May 26.

26.

Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.

Pinker K, Andrzejewski P, Baltzer P, Polanec SH, Sturdza A, Georg D, Helbich TH, Karanikas G, Grimm C, Polterauer S, Poetter R, Wadsak W, Mitterhauser M, Georg P.

PLoS One. 2016 May 11;11(5):e0155333. doi: 10.1371/journal.pone.0155333. eCollection 2016.

27.

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.

Langsteger W, Rezaee A, Loidl W, Geinitz HS, Fitz F, Steinmair M, Broinger G, Pallwien-Prettner L, Beheshti M, Imamovic L, Beheshti M, Rendl G, Hackl D, Tsybrovsky O, Steinmair M, Emmanuel K, Moinfar F, Pirich C, Langsteger W, Bytyqi A, Karanikas G, Mayerhöfer M, Koperek O, Niederle B, Hartenbach M, Beyer T, Herrmann K, Czernin J, Rausch I, Rust P, DiFranco MD, Lassen M, Stadlbauer A, Mayerhöfer ME, Hartenbach M, Hacker M, Beyer T, Binzel K, Magnussen R, Wei W, Knopp MU, Flanigan DC, Kaeding C, Knopp MV, Leisser A, Nejabat M, Hartenbach M, Kramer G, Krainer M, Hacker M, Haug A, Lehnert W, Schmidt K, Kimiaei S, Bronzel M, Kluge A, Wright CL, Binzel K, Zhang J, Wuthrick E, Maniawski P, Knopp MV, Blaickner M, Rados E, Huber A, Dulovits M, Kulkarni H, Wiessalla S, Schuchardt C, Baum RP, Knäusl B, Georg D, Bauer M, Wulkersdorfer B, Wadsak W, Philippe C, Haslacher H, Zeitlinger M, Langer O, Bauer M, Feldmann M, Karch R, Wadsak W, Zeitlinger M, Koepp MJ, Asselin MC, Pataraia E, Langer O, Zeilinger M, Philippe C, Dumanic M, Pichler F, Pilz J, Hacker M, Wadsak W, Mitterhauser M, Nics L, Steiner B, Hacker M, Mitterhauser M, Wadsak W, Traxl A, Wanek T, Kryeziu K, Mairinger S, Stanek J, Berger W, Kuntner C, Langer O, Mairinger S, Wanek T, Traxl A, Krohn M, Stanek J, Filip T, Sauberer M, Kuntner C, Pahnke J, Langer O, Svatunek D, Denk C, Wilkovitsch M, Wanek T, Filip T, Kuntner-Hannes C, Fröhlich J, Mikula H, Denk C, Svatunek D, Wanek T, Mairinger S, Stanek J, Filip T, Fröhlich J, Mikula H, Kuntner-Hannes C, Balber T, Singer J, Fazekas J, Rami-Mark C, Berroterán-Infante N, Jensen-Jarolim E, Wadsak W, Hacker M, Viernstein H, Mitterhauser M, Denk C, Svatunek D, Sohr B, Mikula H, Fröhlich J, Wanek T, Kuntner-Hannes C, Filip T, Pfaff S, Philippe C, Mitterhauser M, Hartenbach M, Hacker M, Wadsak W, Wanek T, Halilbasic E, Visentin M, Mairinger S, Stieger B, Kuntner C, Trauner M, Langer O, Lam P, Aistleitner M, Eichinger R, Artner C, Eidherr H, Vraka C, Haug A, Mitterhauser M, Nics L, Hartenbach M, Hacker M, Wadsak W, Kvaternik H, Müller R, Hausberger D, Zink C, Aigner RM, Cossío U, Asensio M, Montes A, Akhtar S, Te Welscher Y, van Nostrum R, Gómez-Vallejo V, Llop J, VandeVyver F, Barclay T, Lippens N, Troch M, Hehenwarter L, Egger B, Holzmannhofer J, Rodrigues-Radischat M, Pirich C, Pötsch N, Rausch I, Wilhelm D, Weber M, Furtner J, Karanikas G, Wöhrer A, Mitterhauser M, Hacker M, Traub-Weidinger T, Cassou-Mounat T, Balogova S, Nataf V, Calzada M, Huchet V, Kerrou K, Devaux JY, Mohty M, Garderet L, Talbot JN, Stanzel S, Pregartner G, Schwarz T, Bjelic-Radisic V, Liegl-Atzwanger B, Aigner R, Stanzel S, Quehenberger F, Aigner RM, Marković AK, Janković M, Jerković VM, Paskaš M, Pupić G, Džodić R, Popović D, Fornito MC, Familiari D, Koranda P, Polzerová H, Metelková I, Henzlová L, Formánek R, Buriánková E, Kamínek M, Thomson WH, Lewis C, Thomson WH, O'Brien J, James G, Notghi A, Huber H, Stelzmüller I, Wunn R, Mandl M, Fellner F, Lamprecht B, Gabriel M, Fornito MC, Leonardi G, Thomson WH, O'Brien J, James G, Hudzietzová J, Sabol J, Fülöp M.

EJNMMI Res. 2016 Apr;6(Suppl 1):32. doi: 10.1186/s13550-016-0168-9. Epub 2016 Apr 18.

28.

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.

Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.

29.

Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence.

Spick C, Polanec SH, Mitterhauser M, Wadsak W, Anner P, Reiterits B, Haug AR, Hacker M, Beheshti M, Karanikas G.

Anticancer Res. 2015 Dec;35(12):6787-91. Erratum in: Anticancer Res. 2016 Feb;36(2):835.

PMID:
26637897
30.

Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.

Leisser A, Pruscha K, Ubl P, Wadsak W, Mayerhöfer M, Mitterhauser M, Hacker M, Kramer G, Shariat S, Karanikas G, Hartenbach M, Haug AR.

Prostate. 2015 Nov;75(15):1760-7. doi: 10.1002/pros.23061. Epub 2015 Aug 18.

PMID:
26282590
31.

Erratum: "Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F-18-FDG PET" [Med. Phys. 41(12), 121904 (2014)].

Knogler T, El-Rabadi K, Weber M, Karanikas G, Mayerhoefer ME.

Med Phys. 2015 Aug;42(8):4998. doi: 10.1118/1.4923801. No abstract available.

PMID:
26233226
32.

[Protection of the unborn child in diagnostic and interventional radiological procedures].

Hojreh A, Prosch H, Karanikas G, Homolka P, Trattnig S.

Radiologe. 2015 Aug;55(8):663-72. doi: 10.1007/s00117-015-2816-x. Review. German.

PMID:
26220128
33.

Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T.

Magometschnigg HF, Baltzer PA, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1656-1665. doi: 10.1007/s00259-015-3099-1. Epub 2015 Jun 30.

PMID:
26121928
34.

microRNA-21 expression is elevated in esophageal adenocarcinoma after neoadjuvant chemotherapy.

Ilhan-Mutlu A, Tezcan G, Schoppmann SF, Preusser M, Spyridoula K, Karanikas G, Birner P.

Cancer Invest. 2015 Jul;33(6):246-50. doi: 10.3109/07357907.2015.1024319. Epub 2015 May 7.

PMID:
25950983
35.

Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.

Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Knogler T, Sillaber C, Jaeger U, Simonitsch-Klupp I, Ubl P, Müllauer L, Dolak W, Lukas J, Raderer M.

Clin Cancer Res. 2015 Jun 1;21(11):2506-13. doi: 10.1158/1078-0432.CCR-14-2454. Epub 2015 Mar 2.

36.

Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET.

Knogler T, El-Rabadi K, Weber M, Karanikas G, Mayerhoefer ME.

Med Phys. 2014 Dec;41(12):121904. doi: 10.1118/1.4900821. Erratum in: Med Phys. 2015;42:4998. Thomas, Knogler [corrected to Knogler, Thomas; Karem, El-Rabadi [corrected to El-Rabadi, Karem; Michael, Weber [corrected to Weber, Michael]; Georgios, Karanikas [corrected to Karanikas, Georgios]; Marius Erik, Mayerhoefer [corrected to Mayerhoefer, Marius. Med Phys. 2015 Aug;42(8):4998.

PMID:
25471964
37.

Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.

Sesti A, Mayerhoefer M, Weber M, Anner P, Wadsak W, Dudczak R, Haug A, Karanikas G.

Anticancer Res. 2014 Nov;34(11):6647-54.

PMID:
25368270
38.

Hepatic dysfunction contributes to coagulation disturbances in patients undergoing whole body hyperthermia by use of extracorporeal circulation.

Worel N, Knöbl P, Karanikas G, Fuchs EM, Bojic A, Brodowicz T, Jilma P, Zielinski CC, Köstler WJ, Locker GJ.

Int J Artif Organs. 2014 Sep;37(9):1-12.

PMID:
25262634
39.

¹¹C-acetate PET/CT imaging: physiologic uptake, variants, and pitfalls.

Karanikas G, Beheshti M.

PET Clin. 2014 Jul;9(3):339-44. doi: 10.1016/j.cpet.2014.03.006. Epub 2014 May 3. Review.

PMID:
25030397
40.

11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.

Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M.

J Clin Endocrinol Metab. 2014 Nov;99(11):4199-205. doi: 10.1210/jc.2014-1267. Epub 2014 Jul 16.

PMID:
25029418
41.

Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.

Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH.

Clin Cancer Res. 2014 Jul 1;20(13):3540-9. doi: 10.1158/1078-0432.CCR-13-2810.

42.

Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.

Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.

Clin Cancer Res. 2014 Jun 1;20(11):2984-93. doi: 10.1158/1078-0432.CCR-13-3355. Epub 2014 Apr 2.

43.

In search of acute surgical stress biomarkers: Is ghrelin a potential candidate?

Kontoravdis N, Vassilikostas G, Lagoudianakis EE, Pappas A, Seretis C, Panagiotopoulos N, Koronakis N, Chrysikos J, Karanikas G, Manouras I, Legakis I, Voros D.

J Res Med Sci. 2013 Nov;18(11):1016-7. No abstract available.

44.

(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.

Magnaldi S, Mayerhoefer ME, Khameneh A, Schuetz M, Javor D, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.

Anticancer Res. 2014 Feb;34(2):791-5.

PMID:
24511014
45.

Rapid detection of bone metastasis at thoracoabdominal CT: accuracy and efficiency of a new visualization algorithm.

Toth DF, Töpker M, Mayerhöfer ME, Rubin GD, Furtner J, Asenbaum U, Karanikas G, Weber M, Czerny C, Herold CJ, Ringl H.

Radiology. 2014 Mar;270(3):825-33. doi: 10.1148/radiol.13130789. Epub 2013 Dec 10.

PMID:
24475821
46.

Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.

Hahn A, Haeusler D, Kraus C, Höflich AS, Kranz GS, Baldinger P, Savli M, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2014 Aug;35(8):3857-66. doi: 10.1002/hbm.22442. Epub 2014 Jan 17.

PMID:
24443158
47.

Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1).

Philippe C, Nics L, Zeilinger M, Schirmer E, Spreitzer H, Karanikas G, Lanzenberger R, Viernstein H, Wadsak W, Mitterhauser M.

Sci Pharm. 2013 Jul 1;81(3):625-39. doi: 10.3797/scipharm.1306-02. Print 2013 Jul-Sep.

48.

Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO.

Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W.

Appl Radiat Isot. 2013 Dec;82:75-80. doi: 10.1016/j.apradiso.2013.07.023. Epub 2013 Aug 3.

49.

Beta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET.

Toth DF, Raderer M, Wadsak W, Karanikas G.

Anticancer Res. 2013 Aug;33(8):3341-5.

PMID:
23898101
50.

Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.

Mayerhoefer ME, Ba-Ssalamah A, Weber M, Mitterhauser M, Eidherr H, Wadsak W, Raderer M, Trattnig S, Herneth A, Karanikas G.

Eur Radiol. 2013 Jul;23(7):1978-85. doi: 10.1007/s00330-013-2785-2. Epub 2013 Mar 8.

PMID:
23471430

Supplemental Content

Loading ...
Support Center